Immunogenicity of a Recombinant MVA Vector Vaccine Expressing the Prefusion RSV F Protein in Balb/c Mice
: There is a lack of data from further challenge studies to support the efficacy of the rMVA-RSV preF vaccine in terms of protection, but our findings demonstrate a favorable immunogenicity profile of the rMVA-RSV preF vaccine, supporting its further development as a promising RSV vaccine candidate.
Authors
- Feixia Gao
- Jinhui Miao
- Qun Zhang
- Min Liu
- Cheng He
Publication Details
- Journal
- Vaccines
- Published
- 2026-03-31
- DOI
- https://doi.org/10.3390/vaccines14040317
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00